Current Approach to Frontline Systemic Therapy for Advanced Hepatoce…

Lionel Kankeu Fonkoua

Understanding HCC: Perspectives on Diagnosis, Risk Factors, and Trea…

Yale Cancer Center

A. Jaffe

ACG 2023 Highlights: HCC Updates - Diagnosis and Management

ACG 2023 Conference Coverage

R. Wong

Combined Hepatocellular-Cholangiocarcinoma: Diagnosis and Management

Integrity CE

J. Birkness-Gartman

2L Systemic Therapy for Unresectable HCC

Lorenza Rimassa

The Role of Adjuvant Therapy Following HCC Resection

Integrity CE

M. Baretti

ESMO GI 2024 Insights: Ten Years of Improvement in the Treatment of …

Insights from 2024 ESMO GI Annual Meeting

S. L. Chan

Advances in Hepatocellular Carcinoma Diagnosis and Treatment

Scripps Health

A. Singal

Current Unmet Needs in Advanced HCC

Ahmed O. Kaseb

ASCO® GI 2024 Insights: "Evaluating Novel Therapies and ctDNA as a M…

Insights from 2024 ASCO® GI Annual Meeting

R. Mukherji

Approach to the Patient with a Liver Mass

Cedars Sinai

W. Ayoub

Advanced HCC: When to Switch to 2L Treatment - Case Presentation

COR2ED The Heart of Medical Education

T. Vandamme

Disparities Through GI Cancers: Panel Discussion

Total Health

R. Kim, J. Starr

New Guidelines in the Management of Liver Cancer

Yale Cancer Center

T. Taddei

Gallbladder and Bile Duct Cancer: Improving Screening & Treatment Op…

Oncology Data Advisor

M. Hadfield, W. Haque

Advanced HCC Case Discussion: Treatment Options for Patients With Au…

COR2ED The Heart of Medical Education

S. Saab

Hepatocellular Carcinoma - From Screening to Treatment: Current Prac…

Yale Cancer Center

T. Taddei

Intermediate Stage HCC With a Hx of Cirrhosis: Case Presentation and…

Integrity CE

M. Baretti, D. Hsieh, K. Lafaro, F. Escorcia

ASCO® GI 2024 Insights: "Clinical Validation of Northstar Response, …

Insights from 2024 ASCO® GI Annual Meeting

I. Sahin

ASCO® 2023 Insights: "Post Hoc Analysis of Patients With Nonviral Et…

Insights from 2023 ASCO® Annual Meeting

A. Baron